Beacon Financial Advisory
ABBV icon

Beacon Financial Advisory’s AbbVie ABBV Stock Holding History

Beacon Financial Advisory’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.26M Buy
4,816
+54
+1% +$13.8K 0.24% 99
2026
Q2 		$1.2M Buy
4,762
+720
+18% +$155K 0.24% 108
2026
Q1 		$879K Buy
4,042
+124
+3% +$27.5K 0.2% 139
2025
Q4 		$895K Sell
3,918
-5,880
-60% -$1.34M 0.21% 128
2025
Q3 		$2.27M Buy
9,798
+626
+7% +$127K 0.53% 35
2025
Q2 		$1.7M Buy
9,172
+405
+5% +$75.3K 0.44% 47
2025
Q1 		$1.84M Buy
8,767
+63
+0.7% +$12.2K 0.56% 35
2024
Q4 		$1.55M Buy
8,704
+336
+4% +$61.8K 0.5% 44
2024
Q3 		$1.65M Buy
8,368
+157
+2% +$29.3K 0.56% 38
2024
Q2 		$1.41M Buy
8,211
+713
+10% +$118K 0.53% 38
2024
Q1 		$1.37M Sell
7,498
-11
-0.1% -$1.9K 0.66% 29
2023
Q4 		$1.16M Buy
7,509
+6
+0.1% +$875 0.56% 42
2023
Q3 		$1.12M Buy
7,503
+250
+3% +$36.7K 0.62% 42
2023
Q2 		$977K Buy
7,253
+16
+0.2% +$2.35K 0.56% 51
2023
Q1 		$1.15M Buy
7,237
+215
+3% +$32.9K 0.73% 32
2022
Q4 		$1.13M Sell
7,022
-42
-0.6% -$6.44K 0.81% 30
2022
Q3 		$948K Sell
7,064
-3,335
-32% -$479K 0.68% 43
2022
Q2 		$1.59M Buy
10,399
+353
+4% +$53.9K 0.91% 27
2022
Q1 		$1.63M Sell
10,046
-123
-1% -$17.9K 0.78% 33
2021
Q4 		$1.38M Sell
10,169
-90
-0.9% -$10.6K 0.64% 41
2021
Q3 		$1.11M Buy
10,259
+2,809
+38% +$321K 0.58% 49
2021
Q2 		$839K Buy
7,450
+118
+2% +$13.3K 0.45% 74
2021
Q1 		$794K Sell
7,332
-2,792
-28% -$299K 0.45% 79
2020
Q4 		$1.08M Buy
10,124
+994
+11% +$95.5K 0.7% 41
2020
Q3 		$799K Sell
9,130
-2,754
-23% -$259K 0.69% 38
2020
Q2 		$1.17M Buy
11,884
+215
+2% +$18.9K 1.27% 25
2020
Q1 		$889K Sell
11,669
-4,466
-28% -$380K 1.13% 26
2019
Q4 		$1.43M Buy
+16,135
New +$1.34M 1.22% 22

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $40B AUM 30.45% 1-Year Est. Return
B. Metzler seel. Sohn & Co
B. Metzler seel. Sohn & Co Frankfurt, Germany $11.5B AUM 29.17% 1-Year Est. Return

Beacon Financial Advisory's ABBV Position: Q3 2026 in Review

Beacon Financial Advisory increased its AbbVie (ABBV) stake by 1.1% in Q3 2026, buying an estimated $13.8K and bringing the position to 4,816 shares worth $1.26M. The position accounts for 0.24% of the portfolio, ranked #99.

Beacon Financial Advisory first reported a position in ABBV in Q4 2019 and has held it in 28 quarters since. The position peaked at $2.27M in Q3 2025. 1,999 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Beacon Financial Advisory held 4,816 shares of AbbVie worth $1.26M as of Q3 2026.
  • Beacon Financial Advisory bought 54 AbbVie shares in Q3 2026, an estimated $13.8K.
  • AbbVie made up 0.24% of Beacon Financial Advisory's portfolio in Q3 2026, its #99 holding.
  • Beacon Financial Advisory first reported a position in AbbVie in Q4 2019 and has held it in 28 quarters since.
  • Beacon Financial Advisory's AbbVie position peaked at $2.27M in Q3 2025.
  • 1,999 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Beacon Financial Advisory's 13F filing for Q3 2026, filed 16 Oct 2026.